MARINUS PHARMACEUTICALS, INC. (NASDAQ: MRNS) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Marinus Pharmaceuticals, Inc.

NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Did you purchase your shares between March 17, 2021 and May 7, 2024, inclusive? Do you want to discuss your rights? If you purchased or acquired Marinus securities, and/or would like to discuss your legal rights and options please visit Marinus Pharmaceuticals, Inc. Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com. According to the Complaint, Defendants failed to ...